Phenomenex has introduced Strata-X-Drug B Plus, a solid-phase extraction (SPE) sample preparation product for urine drug testing in clinical and forensic toxicology. An expansion of Phenomenex’s drug testing product line, the new Drug B Plus option joins the original Strata-X-Drug B, which is designated for matrices such as plasma, whole blood and serum.
The new Drug B Plus product features Phenomenex’s Solvent Shielding Technology, which enables an enzyme hydrolysis to be carried out directly in the microplate well, reducing transfer steps, time requirements and cost. And the hydrolysis solution can be held for six hours or more, providing flexibility in protocol planning.
To meet the throughput demands of high-volume drug testing laboratories, Strata-X-Drug B Plus is available in 96-well plate format. The product ensures high recoveries, low variation, time savings and reduced solvent requirements, and its protocol eliminates conditioning and equilibration steps from traditional SPE methods. The new sorbent enables extraction of more than 22 drugs of abuse.